Clinical and Diagnostic Parasitology: Laboratory Identification Techniques, Biomarkers, and Evidence-Based Therapeutic Management Strategies

Abstract

Clinical & Diagnostic Parasitology is critical for identifying, diagnosing and managing parasites that are worldwide human health problems. The research discusses more advanced lab methodologies such as conventional microscopy, culture, serological assays, and modern molecular diagnostics including Polymerase Chain Reaction (PCR) & Nucleic Acid Tests. The use of biomarkers in parasitology has improved the ability to detect and diagnose parasitic diseases, leading to quicker clinical intervention and improved patient care through better sensitivity, specificity and early detection of disease. Biomarkers are derived from the immune response of the host, antigens of the parasite, and DNA from the parasite, which are being used more frequently to monitor disease status, assess prognosis, and evaluate therapy. The clinical efficacy and epidemiologic surveillance of antiparasitic therapies are now based on objective data that support appropriate drug selection, resistance monitoring, and individualized treatment choices. The recent advances in diagnostic technology & targeted therapies will result in improved disease control & minimization of the complications associated with these infections. The role of accurate lab diagnosis, epidemiologic surveillance and collaborative disciplines in the global public health outcomes will also be discussed. This review provides a comprehensive overview of the new and innovative diagnostics and therapeutics available for making effective clinical decisions, treating parasitic infections in endemic and non-endemic areas.

Keywords: Clinical parasitology, diagnostic techniques, laboratory identification, parasitic infections, biomarkers, molecular diagnosis, serology, microscopy, evidence-based therapy, antiparasitic treatment